Brief: Altamira Therapeutics Announces Reverse Stock Split

Altamira Therapeutics

24/10/2022 13:52

Oct 24 (Reuters) - Altamira Therapeutics Ltd  CYTO.O :
    * ALTAMIRA THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT
    * ALTAMIRA THERAPEUTICS LTD - APPROVED A REVERSE STOCK SPLIT
OF
ITS COMMON SHARES AT A RATIO OF 1-FOR-20
    * ALTAMIRA THERAPEUTICS LTD - REVERSE STOCK SPLIT IS
PRIMARILY
BEING EFFECTED TO REGAIN COMPLIANCE WITH $1.00 MINIMUM BID PRICE
REQUIREMENT
    * ALTAMIRA THERAPEUTICS LTD - REVERSE STOCK SPLIT IS
EXPECTED TO
BECOME EFFECTIVE AT MARKET OPENING ON OCTOBER 25, 2022

Source text for Eikon:  ID:nGNX8rHf7n 
Further company coverage:  CYTO.O 
 ((Reuters.Briefs@thomsonreuters.com;))